Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor

Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex

(2019) Motohiro Okada et al.   NEUROPHARMACOLOGY

Amantadine Combines Astroglial System Xc− Activation with Glutamate/NMDA Receptor Inhibition

(2019) Tomosuke Nakano et al.   Biomolecules

Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

(2018) Michael J Curtis et al.   BRITISH JOURNAL OF PHARMACOLOGY

Chronic clozapine treatment restrains via HDAC2 the performance of mGlu2 receptor agonism in a rodent model of antipsychotic activity

(2018) Mario de la Fuente Revenga et al.   NEUROPSYCHOPHARMACOLOGY

Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites

(2018) Kouji Fukuyama et al.   BRITISH JOURNAL OF PHARMACOLOGY

Targeting gap junction in epilepsy: Perspectives and challenges

(2018) Qin Li et al.   BIOMEDICINE & PHARMACOTHERAPY

Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission

(2018) Kouji Fukuyama et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Connexins and pannexins: At the junction of neuro-glial homeostasis & disease

(2017) Andrew S. Lapato et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis

(2016) Dan Siskind et al.   BRITISH JOURNAL OF PSYCHIATRY

Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase

(2016) Lulu Jiang et al.   Journal of Neuroinflammation

The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway

(2016) Zhiwen Zeng et al.   MOLECULAR NEUROBIOLOGY

Thalamic Inhibition: Diverse Sources, Diverse Scales

(2016) Michael M. Halassa et al.   TRENDS IN NEUROSCIENCES

Inhibition of SystemXc−Transporter Attenuates Autoimmune Inflammatory Demyelination

(2015) Kirsten S. Evonuk et al.   JOURNAL OF IMMUNOLOGY

Zonisamide regulates basal ganglia transmission via astroglial kynurenine pathway

(2013) Kouji Fukuyama et al.   NEUROPHARMACOLOGY

Effects of meclofenamic acid on limbic epileptogenesis in mice kindling models

(2013) Miaomiao Jin et al.   NEUROSCIENCE LETTERS

The Cystine/Glutamate Antiporter System xc− in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities

(2012) Jan Lewerenz et al.   ANTIOXIDANTS & REDOX SIGNALING

Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes

(2012) Shunske Tanahashi et al.   BRITISH JOURNAL OF PHARMACOLOGY

ONO-2506 inhibits spike-wave discharges in a genetic animal model without affecting traditional convulsive tests via gliotransmission regulation

(2012) Satoshi Yamamura et al.   BRITISH JOURNAL OF PHARMACOLOGY

Clozapine: dangerous orphan or neglected friend?

(2011) Saeed Farooq et al.   BRITISH JOURNAL OF PSYCHIATRY

Dopamine D2 and serotonin 5-HT1A receptors mediate the actions of aripiprazole in mesocortical and mesoaccumbens transmission

(2011) Shunsuke Tanahashi et al.   NEUROPHARMACOLOGY

Selective determination of cysteines through precolumn double-labeling and liquid chromatography followed by detection of intramolecular FRET

(2010) Makoto Yoshitake et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease

(2010) Colleen M. Niswender et al.   Annual Review of Pharmacology and Toxicology

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex

(2010) Keiko Ohoyama et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of zotepine on extracellular levels of monoamine, GABA and glutamate in rat prefrontal cortex

(2009) S Yamamura et al.   BRITISH JOURNAL OF PHARMACOLOGY

Loss of function of glial gap junctions may cause severe cognitive impairments in schizophrenia

(2009) Bernhard Mitterauer   MEDICAL HYPOTHESES

Change detection by thalamic reticular neurons

(2009) Xiong-Jie Yu et al.   NATURE NEUROSCIENCE

The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia

(2009) Viviane Labrie et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Effects of quetiapine on monoamine, GABA, and glutamate release in rat prefrontal cortex

(2009) Satoshi Yamamura et al.   PSYCHOPHARMACOLOGY

Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)

(2008) M. J. Fell et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

(2008) J. A. Lieberman et al.   PHARMACOLOGICAL REVIEWS